<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f1 { font-family:ff0,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f3 { font-family:ff2,sans-serif; font-weight:bold; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="612" height="792" src="page77.png"">
<div class="txt" style="position:absolute; left:75px; top:31px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Revision of the Pharmaceutical Affairs Act, etc. (Act No. 84 of 2013. Less than or equal</span></div>
<div class="txt" style="position:absolute; left:78px; top:48px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">"Revision Law") The Pharmaceutical Affairs Act prior to the revision by the provisions</span></div>
<div class="txt" style="position:absolute; left:75px; top:65px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">of Article 1 (Act No. 145 of 1960. Hereinafter referred to as the "former Pharmaceutical</span></div>
<div class="txt" style="position:absolute; left:75px; top:83px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Affairs Law.") Medical devices approved under Article 14 or Article 19-2 or certified</span></div>
<div class="txt" style="position:absolute; left:75px; top:100px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">under Article 23-2 of the former Pharmaceutical Affairs Act (Cabinet Order on</span></div>
<div class="txt" style="position:absolute; left:75px; top:118px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Development, etc. and Transitional Measures of relevant Cabinet Orders</span></div>
<div class="txt" style="position:absolute; left:75px; top:135px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">accompanying the enforcement of the Act for Revising Article 63 of the</span></div>
<div class="txt" style="position:absolute; left:75px; top:152px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Supplementary Provisions of the Revising Act or the Act for Revising Part of the</span></div>
<div class="txt" style="position:absolute; left:75px; top:169px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Pharmaceutical Affairs Act, etc. (Cabinet Order No. 269 of 2008). Hereinafter referred</span></div>
<div class="txt" style="position:absolute; left:75px; top:187px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">to as "Revised Cabinet Order" in this paragraph) (Including those approved under</span></div>
<div class="txt" style="position:absolute; left:75px; top:204px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Article 14 or Article 19-2 of the Old Pharmaceutical Affairs Act or those approved</span></div>
<div class="txt" style="position:absolute; left:75px; top:221px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">under Article 23-2 of the Old Pharmaceutical Affairs Act for which the provisions then</span></div>
<div class="txt" style="position:absolute; left:75px; top:238px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">in force shall remain applicable pursuant to the provisions of Article 18) In the case of</span></div>
<div class="txt" style="position:absolute; left:75px; top:256px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">medical devices that have obtained approval under Article 14 or Article 19-2 of the Old</span></div>
<div class="txt" style="position:absolute; left:75px; top:273px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Pharmaceutical Affairs Act or approval under Article 23-2 of the Old Pharmaceutical</span></div>
<div class="txt" style="position:absolute; left:75px; top:290px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Affairs Act for which the provisions then in force shall remain applicable pursuant to</span></div>
<div class="txt" style="position:absolute; left:75px; top:308px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">the provisions of Article 63 of the Supplementary Provisions of the Revised Act or</span></div>
<div class="txt" style="position:absolute; left:75px; top:325px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Article 18 of the Revised Cabinet Order, or approval under Article 23-2 of the Old</span></div>
<div class="txt" style="position:absolute; left:75px; top:342px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Pharmaceutical Affairs Act A medical device other than a medical device specified by</span></div>
<div class="txt" style="position:absolute; left:75px; top:360px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">the Minister of Health, Labour and Welfare as prescribed in Article 4, paragraph (1) of</span></div>
<div class="txt" style="position:absolute; left:75px; top:377px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">the Ministerial Ordinance on Standards for Manufacturing Control and Quality Control</span></div>
<div class="txt" style="position:absolute; left:75px; top:394px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">of Medical Devices and in-Vitro Diagnostics prior to the revision pursuant to Article 9</span></div>
<div class="txt" style="position:absolute; left:75px; top:412px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">of the Revised Ministerial Ordinance (excluding those approved by the Minister of</span></div>
<div class="txt" style="position:absolute; left:75px; top:429px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Health, Labour and Welfare as medical devices capable of controlling design and</span></div>
<div class="txt" style="position:absolute; left:75px; top:446px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">development). And in vitro diagnostic drugs that have received approval under Article</span></div>
<div class="txt" style="position:absolute; left:75px; top:463px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">14 or Article 19-2 of the Old Pharmaceutical Affairs Act or approval under Article 23-2</span></div>
<div class="txt" style="position:absolute; left:75px; top:481px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">of the Old Pharmaceutical Affairs Act at the time of enforcement of the revised</span></div>
<div class="txt" style="position:absolute; left:75px; top:498px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Ministerial Ordinance (including approval under Article 14 or Article 19-2 of the Old</span></div>
<div class="txt" style="position:absolute; left:75px; top:515px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Pharmaceutical Affairs Act, or approval under Article 23 of the Old Pharmaceutical</span></div>
<div class="txt" style="position:absolute; left:75px; top:533px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Affairs Act that can be approved for development of pharmaceuticals other than those</span></div>
<div class="txt" style="position:absolute; left:75px; top:550px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">approved by the Minister of Health and Labour). The provisions of Articles 30 to 36-2</span></div>
<div class="txt" style="position:absolute; left:75px; top:567px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">of the Ministerial Ordinance on Standards for Manufacturing Control and Quality</span></div>
<div class="txt" style="position:absolute; left:75px; top:585px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Control of Medical Devices and in Vitro Diagnostics amended by this Ministerial</span></div>
<div class="txt" style="position:absolute; left:75px; top:602px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Ordinance shall not apply.</span></div>
<div class="txt" style="position:absolute; left:101px; top:631px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Supplementary Provisions (</span><span class="f3" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">ã€‡ </span><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Ordinance of the Ministry of Health, Labour and</span></div>
<div class="txt" style="position:absolute; left:63px; top:648px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Welfare No. 84 of may 2, 2022) Extract</span></div>
<div class="txt" style="position:absolute; left:78px; top:670px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">(Effective Date)</span></div>
<div class="txt" style="position:absolute; left:66px; top:687px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">(1) this Ministerial Ordinance shall come into effect as of the date of promulgation of</span></div>
<div class="txt" style="position:absolute; left:74px; top:704px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">the Act for Partial Revision of the Act on Securing Quality, Effectiveness and Safety of</span></div>
<div class="txt" style="position:absolute; left:74px; top:721px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Pharmaceuticals, Medical Devices, etc. (Act No. 47 of 1992).</span></div>
<div class="txt" style="position:absolute; left:101px; top:750px;"><span class="f2" style="font-size:11px;vertical-align:baseline;color:rgba(49,49,49,1);">Supplementary Provisions (Ordinance of the Ministry of Health, Labour and</span></div>
</body>
</html>
